Fluicell Investor Newsletter 04, 2022

Dr. Nelson Khoo joined Fluicell in April this year as Chief Business Development and Sales Officer. In the…

Read more
09 Sep 2022

Extra bolagsstämma

Aktieägarna i Fluicell AB, org. nr. 556889-3282, kallas härmed till extra bolagsstämma fredagen den 30 september 2022 kl….

Read more
29 Aug 2022

Now you can do both!

We are excited to present the Biopixlar Switching Head, a new addon to the Biopixlar platform that combines…

Read more
26 Aug 2022

Fluicell is growing

At Fluicell, we are currently intensifying our product sales activities and our regenerative medicine development program and are…

Read more
22 Aug 2022

Fluicell publishes report for the second quarter 2022

Today, August 18 2022, Fluicell publishes the interim report for the period April 1 to June 30, 2022….

Read more
18 Aug 2022

Fluicell CEO Newsletter 03, 2022

As we head towards the summer holiday season, Victoire Viannay gives an update in the latest issue of…

Read more
30 Jun 2022

Fluicell among ten most innovative 3D printing companies 2022

In an article published today, All3DP names Fluicell as one of the ten most innovative 3D printing companies…

Read more
22 Jun 2022

2022 BioPen & Biozone 6 Software Release Live Demo

Get the first glimpse of all the news in the latest version of the BioPen and Biozone 6…

Read more
02 Jun 2022

Combining computation and single-cell microfluidics to capture biological complexity

Capturing the complexity of living cells is a major challenge for biological research. Cell population heterogeneity in physical,…

Read more
23 May 2022